These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7493197)

  • 21. [Medical economy--a new challenge for physicians].
    Beeler I; Szucs TD
    Praxis (Bern 1994); 2000 May; 89(20):861-7. PubMed ID: 10865509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
    Neumann PJ
    J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the cost-effectiveness of pharmacologic therapy: where we've been and where we're going.
    Epstein AM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S1-5. PubMed ID: 7493192
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
    Zegeye EA; Mbonigaba J; Kaye SB; Wilkinson T
    Appl Health Econ Health Policy; 2017 Feb; 15(1):33-43. PubMed ID: 27637919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A bootstrap approach to medical decision analysis.
    Mennemeyer ST; Cyr LP
    J Health Econ; 1997 Dec; 16(6):741-7. PubMed ID: 10176782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current capacity and future development of economic evaluation for policy decision-making: a survey among researchers and decision-makers in Thailand.
    Chaikledkaew U; Lertpitakpong C; Teerawattananon Y; Thavorncharoensap M; Tangcharoensathien V
    Value Health; 2009; 12 Suppl 3():S31-5. PubMed ID: 20586978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating AIDS: the economic issues.
    Drummond M; Davies L
    Health Policy; 1988 Aug; 10(1):1-19. PubMed ID: 10312592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision and cost-effectiveness analysis.
    Marley DS
    J Fam Pract; 1990 Feb; 30(2):233, 236. PubMed ID: 2105374
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost effectiveness and AIDS: science or marketing? Proceedings of a workshop. Washington, D.C., January 28, 1995.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S1-32. PubMed ID: 7493191
    [No Abstract]   [Full Text] [Related]  

  • 33. [Economic studies and decision analysis as tools for decision making].
    Rodríguez-Pimentel L; Silva-Romo R; Wacher-Rodarte N
    Rev Med Inst Mex Seguro Soc; 2007; 45(3):297-304. PubMed ID: 17692169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiological and economic consequences of AIDS clinical trials.
    Paltiel AD; Kaplan EH
    J Acquir Immune Defic Syndr (1988); 1993 Feb; 6(2):179-90. PubMed ID: 8433283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision analysis: a tool for infection control.
    Nettleman MD
    Infect Control Hosp Epidemiol; 1988 Feb; 9(2):88-91. PubMed ID: 3125245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical protocols].
    Rodríguez Artalejo F; Ortún Rubio V
    Med Clin (Barc); 1990 Sep; 95(8):309-16. PubMed ID: 2283913
    [No Abstract]   [Full Text] [Related]  

  • 37. Decision Modeling for Cost-Utility Analysis.
    Kuntz KM
    Value Health; 2016; 19(6):700-701. PubMed ID: 27712693
    [No Abstract]   [Full Text] [Related]  

  • 38. Deep imagination is a close to optimal policy for planning in large decision trees under limited resources.
    Mastrogiuseppe C; Moreno-Bote R
    Sci Rep; 2022 Jun; 12(1):10411. PubMed ID: 35729320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of decision analysis.
    Kallmes DF
    Acad Radiol; 1998 Sep; 5 Suppl 2():S264-5. PubMed ID: 9750827
    [No Abstract]   [Full Text] [Related]  

  • 40. Understanding the essentials of economic evaluation.
    Schmid GP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S6-13. PubMed ID: 7493197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.